China Digest: Muliang eyes $40m Nasdaq IPO; neoX Biotech, Resproly raise fresh capital

China Digest: Muliang eyes $40m Nasdaq IPO; neoX Biotech, Resproly raise fresh capital

Source: Markus Winkler/Unsplash

Chinese fertiliser producer Muliang is seeking to raise $40 million in a Nasdaq IPO, while biotech startup neoX Biotech and inhalation therapy developer Resproly have closed new funding rounds to expand operations.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter